234 related articles for article (PubMed ID: 8019766)
1. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
Kappelle AC; Biessels G; Bravenboer B; van Buren T; Traber J; de Wildt DJ; Gispen WH
Br J Pharmacol; 1994 Mar; 111(3):887-93. PubMed ID: 8019766
[TBL] [Abstract][Full Text] [Related]
2. Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat.
Kappelle AC; Biessels GJ; Van Buren T; Erkelens DW; De Wildt DJ; Gispen WH
Eur J Pharmacol; 1993 Nov; 250(1):43-9. PubMed ID: 8119324
[TBL] [Abstract][Full Text] [Related]
3. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
Kappelle AC; Bravenboer B; van Buren T; Traber J; Erkelens DW; Gispen WH
Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365
[TBL] [Abstract][Full Text] [Related]
4. Failure of nimodipine to prevent or correct the long-term nerve conduction defect and increased neuronal Ca(2+)-currents in the diabetic BB/W-rat.
Ristic H; Wiley JW; Hall KE; Sima AA
Diabetes Res Clin Pract; 1996 May; 32(3):135-40. PubMed ID: 8858201
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
Biessels GJ; ter Laak MP; Kamal A; Gispen WH
Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
[TBL] [Abstract][Full Text] [Related]
6. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
[TBL] [Abstract][Full Text] [Related]
7. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats.
Sima AA; Zhang W; Xu G; Sugimoto K; Guberski D; Yorek MA
Diabetologia; 2000 Jun; 43(6):786-93. PubMed ID: 10907124
[TBL] [Abstract][Full Text] [Related]
8. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
Stevens MJ; Zhang W; Li F; Sima AA
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E497-505. PubMed ID: 15126237
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Maxfield EK; Cameron NE; Cotter MA; Dines KC
Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
[TBL] [Abstract][Full Text] [Related]
11. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
[TBL] [Abstract][Full Text] [Related]
12. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
Cameron NE; Cotter MA; Dines KC; Robertson S; Cox D
Br J Pharmacol; 1993 Aug; 109(4):972-9. PubMed ID: 8401950
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic deficit of sympathetic nerves: a cause for disturbed sciatic nerve blood flow responsiveness in diabetic rats.
Van Buren T; Kasbergen CM; Gispen WH; De Wildt DJ
Eur J Pharmacol; 1996 Feb; 296(3):277-83. PubMed ID: 8904079
[TBL] [Abstract][Full Text] [Related]
14. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
Bravenboer B; Kappelle AC; van Buren T; Erkelens DW; Gispen WH
Acta Diabetol; 1993; 30(1):21-4. PubMed ID: 8392402
[TBL] [Abstract][Full Text] [Related]
15. Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Hara T; Mori K; Naruse K; Fukasawa H; Kakuta H; Sakamoto N
Eur J Pharmacol; 1996 Oct; 313(3):201-9. PubMed ID: 8911916
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.
Sima AA; Zhang W; Li ZG; Murakawa Y; Pierson CR
Diabetes; 2004 Jun; 53(6):1556-63. PubMed ID: 15161761
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
[TBL] [Abstract][Full Text] [Related]
18. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
Cameron NE; Dines KC; Cotter MA
Diabetologia; 1994 Dec; 37(12):1209-15. PubMed ID: 7895950
[TBL] [Abstract][Full Text] [Related]
19. Dorsal root ganglia microenvironment of female BB Wistar diabetic rats with mild neuropathy.
Zochodne DW; Ho LT; Allison JA
J Neurol Sci; 1994 Dec; 127(1):36-42. PubMed ID: 7699389
[TBL] [Abstract][Full Text] [Related]
20. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
Cotter MA; Dines KC; Cameron NE
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
